Cargando…

IL-11 in multiple sclerosis

Detalles Bibliográficos
Autores principales:	Zhang, Xin, Putoczki, Tracy, Markovic-Plese, Silva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741686/ https://www.ncbi.nlm.nih.gov/pubmed/26452137

Ejemplares similares

Targeting IL-11 signaling in colon cancer
por: Ernst, Matthias, et al.
Publicado: (2013)

Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis
por: Sha, Yonggang, et al.
Publicado: (2016)

Regulation of Suppressors of Cytokine Signaling as a Therapeutic Approach in Autoimmune Diseases, with an Emphasis on Multiple Sclerosis
por: Ramgolam, Vinod S., et al.
Publicado: (2011)

Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study
por: Plummer, Prudence, et al.
Publicado: (2022)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

Emerging roles for the IL-6 family of cytokines in pancreatic cancer
por: van Duijneveldt, Gemma, et al.
Publicado: (2020)

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
por: Dwyer, Michael G., et al.
Publicado: (2015)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
por: Metcalfe, Riley D., et al.
Publicado: (2020)

Multiples sclerosis in India
por: Khadilkar, Satish V.
Publicado: (2015)

Multiple Sclerosis in India
por: Goyal, Vinay
Publicado: (2018)

The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis
por: Stuart, Sarah F., et al.
Publicado: (2023)

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2014)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

Molecular Research in Multiple Sclerosis
por: Fucito, Maurine, et al.
Publicado: (2022)

Improving communication with multiple sclerosis patients
por: Alroughani, Raed A.
Publicado: (2015)

Sequencing the immunopathologic heterogeneity in multiple sclerosis
por: Antel, Jack P, et al.
Publicado: (2015)

Multiple Sclerosis: From Molecules to Treatment
por: Broadley, Simon A
Publicado: (2013)

Multiple Sclerosis, Viruses, and New Vaccines
por: Maple, Peter A. C.
Publicado: (2021)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Personalized Diagnosis and Therapy for Multiple Sclerosis
por: Ramo-Tello, Cristina
Publicado: (2022)

Molecule of the month: miRNA and Multiple Sclerosis
por: Shapshak, Paul
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
por: Messinis, Lambros, et al.
Publicado: (2018)

Prospects of siponimod in secondary progressive multiple sclerosis
por: McGinley, Marisa, et al.
Publicado: (2018)

The Long Road of Immunotherapeutics against Multiple Sclerosis †
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

Cellular and Molecular Mechanisms in the Pathogenesis of Multiple Sclerosis
por: Wan, Edwin C. K.
Publicado: (2020)

Advances in Multiple Sclerosis Research–Series I
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

The relationship between multiple sclerosis and neuropsychiatric syndromes
por: McLoughlin, James, et al.
Publicado: (2017)

Response of the multiple sclerosis community to COVID-19
por: Ciccarelli, Olga, et al.
Publicado: (2020)

Multiple Sclerosis: Diagnosis, Management, and Future Opportunities
por: Maida, Elisabetta, et al.
Publicado: (2023)

IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts
por: Adami, Eleonora, et al.
Publicado: (2021)

Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment
Publicado: (2015)

TLR2 – an innate immune checkpoint in multiple sclerosis
por: Hossain, Md Jakir, et al.
Publicado: (2015)

Multiple sclerosis in Isfahan, Iran: Past, Present and Future
por: Etemadifar, Masoud, et al.
Publicado: (2012)

Multiple sclerosis in the Middle East and North Africa region
por: Khoury, Samia J, et al.
Publicado: (2020)

Editorial to Special Issue “Cognitive Involvement in Multiple Sclerosis”
por: Lanzillo, Roberta
Publicado: (2022)

The dynamics of the immune system and gut in the pathophysiology of multiple sclerosis
por: eBioMedicine
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2f2m0q0hv0srfo42r19dqf4gck